Find it in seconds.
TMO
30 filings
Timeline Columns Start Research 8-K Categories
10-Q Quarterly 6
2025 Q4
2025-10-31 · 59 pg (+8)
Q3 2025 Results
View Filing →
2025 Q3
2025-08-01 · 55 pg (+6)
Q2 2025 Results
View Filing →
2025 Q2
2025-05-02 · 45 pg (+3)
Q1 2025 Results
Financial data not available in provided excerpt
View Filing →
2024 Q4
2024-11-01 · 51 pg
Q3 2024 Results
View Filing →
2024 Q3
2024-08-02 · 49 pg
Q2 2024 Results
View Filing →
2024 Q2
2024-05-03 · 42 pg
Q1 2024 Results
View Filing →
10-K Annual 2
2025 Q1
2025-02-20 · 130 pg (-4)
FY24 2024 Results
📌 Company issued new senior notes with maturities ranging from 2028-2050, indicating continued debt refinancing activities
View Filing →
2024 Q1
2024-02-22 · 134 pg
FY2023 2023 Results
📌 Completed acquisitions of The Binding Site Group (January 2023), CorEvitas LLC (August 2023), and Olink Holding AB (October 2023) to expand specialty diagnostics and laboratory capabilities
View Filing →
8-K Events 20
2025 Q4
2025-12-01
Issued €2.09 billion in Senior Notes due 2027 and 2035
View Filing →
2025-10-29
Acquired Clario Holdings for approximately $8.875 billion in cash
$8.875 billion
View Filing →
2025-10-22
Q3 2025 Earnings
Q3 2025 results for quarter ended Sept 27, 2025
View Filing →
2025-10-07
Debt Offering
$2.5B notes issued, rates 4.2%-4.9%, maturities 2031-2037
View Filing →
2025 Q3
2025-09-02
Acquired Solventum Purification Business
Completed acquisition of Solventum Corporation's purification and filtration business
View Filing →
2025-07-23
Q2 2025 Earnings
Financial results for quarter ended June 28, 2025
View Filing →
2025-07-23
CFO Succession
Stephen Williamson retiring March 31, 2026; James Meyer appointed CFO March 1, 2026
View Filing →
2025 Q2
2025-05-28
Annual Shareholder Meeting
Executive compensation rejected 111M for vs 201M against
View Filing →
2025-05-22
CEO Retention Award
$60M performance equity grant to CEO through 2030
View Filing →
2025-04-23
Q1 2025 Earnings
Financial results for quarter ended March 29, 2025
View Filing →
2025 Q1
2025-02-25
Acquired Solventum Purification Unit
$4.1B cash deal, close by end 2025
View Filing →
2025-02-19
Board Expansion - New Director
Karen S. Lynch elected to Board, expanded to 12 members
View Filing →
2025-01-30
Q4 2024 Earnings
Financial results for quarter and year ended Dec 31, 2024
View Filing →
2024 Q4
2024-10-23
Q3 2024 Earnings
Q3 2024 financial results announced
View Filing →
2024 Q3
2024-07-24
Q2 Earnings
Financial results for quarter ended June 29, 2024
View Filing →
2024-07-10
Olink Tender Offer Completed
Tender offer for Olink Holding AB expired and results announced
View Filing →
2024 Q2
2024-05-24
Annual Shareholder Meeting
11 directors elected, executive compensation approved, majority voting proposal rejected
View Filing →
2024-04-24
Q1 2024 Earnings
Q1 2024 financial results announced
View Filing →
2024 Q1
2024-01-31
Q4 2023 Earnings
Financial results for fiscal quarter and year ended Dec 31, 2023
View Filing →
2023 Q4
2023-12-05
Debt Offering
$2.5B notes issued: $1B 5.000% 2026, $1B 5.000% 2029, $500M 5.200% 2034
View Filing →